Acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) following treatment for ovarian cancer

被引：0
|
作者：
Gupta, B. [1 ]
Sait, S. N. [1 ]
Block, A. W. [1 ]
Ford, L. A. [1 ]
Moysich, K. B. [1 ]
Baer, M. R. [1 ]
机构：
[1] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
17506
引用
收藏
页数：1
相关论文
共 50 条
  • [11] CYTOGENETIC EVOLUTION FOLLOWING TRANSFORMATION OF MYELODYSPLASTIC SYNDROME (MDS) TO ACUTE MYELOGENOUS LEUKEMIA (AML)
    GHADDAR, H
    STASS, S
    CORK, A
    ESTEY, E
    BLOOD, 1993, 82 (10) : A376 - A376
  • [12] Analysis of mutations associated with response to glasdegib in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)
    Ching, Keith A.
    Huang, Donghui
    Wang, Kai
    Ozeck, Mark
    Lira, Paul
    Gao, Jingjin
    Bienkowska, Jadwiga
    Rejto, Paul
    Hardwick, James
    O'Brien, Thomas
    Chan, Geoffrey
    CANCER RESEARCH, 2018, 78 (13)
  • [13] Lenalidomide and Risk of Acute Myeloid Leukemia (AML) Transformation Among Myelodysplastic Syndrome (MDS) Patients
    Rollison, Dana E.
    Shain, Kenneth H.
    Lee, Ji-Hyun
    Hampras, Shalaka S.
    Fulp, William
    Fisher, Kate
    Al Ali, Najla H.
    Padron, Eric
    Lancet, Jeffrey
    Xu, Qiang
    Knight, Robert D.
    List, Alan F.
    Dalton, William
    Komrokji, Rami
    BLOOD, 2014, 124 (21)
  • [14] Relationship of progression to acute myeloid leukemia (AML) from myelodysplastic syndrome (MDS) and cytogenetic status
    Hellstrom-Lindberg, E.
    Fenaux, P.
    Mufti, G. J.
    List, A. F.
    Santini, V.
    Gore, S.
    Seymour, J. F.
    Backstrom, J.
    McKenzie, D.
    Beach, C. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [15] Clinical relevance of circulating myeloperoxidase (MPO) in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)
    Jilani, I
    Vincenti, T
    Faraji, H
    Giles, FJ
    Estey, E
    Kantarjian, HM
    Albitar, M
    BLOOD, 2004, 104 (11) : 305A - 305A
  • [16] Autologous bone marrow transplantation for patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS
    DeWitte, T
    VanBiezen, A
    Hermans, J
    Labopin, M
    Runde, V
    Or, R
    Meloni, G
    Mauri, SB
    Carella, A
    Apperley, J
    Gratwohl, A
    Laporte, JP
    BLOOD, 1997, 90 (10) : 3853 - 3857
  • [17] LOW-DOSE CYTOSINE-ARABINOSIDE IN THE TREATMENT OF ACUTE MYELOID-LEUKEMIA (AML) AND MYELODYSPLASTIC SYNDROME (MDS)
    WEH, HJ
    ZSCHABER, R
    HOSSFELD, DK
    BLUT, 1984, 48 (04): : 239 - 242
  • [18] Treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) relapsing after allogeneic hematopoietic cell transplantation (HCT).
    Chiattone, A.
    Andersson, B.
    Bashir, Q.
    Landau, D.
    Rondon, G.
    Nieto, Y.
    Al Atrash, G.
    Giralt, S.
    Champlin, R. E.
    De Lima, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [19] Incidence of secondary myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) in patients with ovarian or breast cancer in a real-world setting in the United States
    Shenolikar, Rahul
    Durden, Emily
    Meyer, Nicole
    Lenhart, Gregory
    Moore, Kathleen
    GYNECOLOGIC ONCOLOGY, 2018, 151 (02) : 190 - 195
  • [20] MYC Expression Is Prognostic in Therapy Related Acute Myeloid Leukemia (AML) and AML with Myelodysplastic Syndrome (MDS)-Related Changes
    Ohanian, Maro
    Rozovski, Uri
    Kantarjian, Hagop M.
    Loghavi, Sanam
    Huh, Yang O.
    Abruzzo, Lynne
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Andreeff, Michael
    Kornblau, Steven M.
    Borthakur, Gautam
    Nguyen, Martin
    Stingo, Francesco
    Hu, Peter
    Fox, Patricia
    Medeiros, L. Jeffrey
    Estrov, Zeev
    Bueso-Ramos, Carlos E.
    Cortes, Jorge E.
    BLOOD, 2014, 124 (21)
12345